NRON, known for its role in cancer-related immune responses, including T-cell activation, showed downregulated expression in our study, with the most significant decrease observed in the CPt + SAHA treatment combination, despite the limited literature on its involvement in glioblastoma [90]. This evidence concerns the gene NRON and glioblastoma.